Catherine Ramsey
Stock Analyst at Baird
(3.38)
# 917
Out of 5,154 analysts
56
Total ratings
41.86%
Success rate
8.68%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Catherine Ramsey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NTRA Natera | Maintains: Outperform | $239 → $257 | $198.13 | +29.71% | 7 | Feb 27, 2026 | |
| CSTL Castle Biosciences | Maintains: Outperform | $41 → $44 | $27.12 | +62.24% | 10 | Feb 27, 2026 | |
| ILMN Illumina | Maintains: Neutral | $105 → $109 | $124.62 | -12.53% | 7 | Oct 31, 2025 | |
| RVTY Revvity | Maintains: Outperform | $122 → $123 | $91.34 | +34.66% | 6 | Oct 28, 2025 | |
| WAT Waters | Maintains: Outperform | $374 → $352 | $302.54 | +16.35% | 11 | Jul 16, 2025 | |
| TWST Twist Bioscience | Maintains: Outperform | $54 → $44 | $46.94 | -6.26% | 7 | May 6, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Outperform | $695 → $665 | $501.97 | +32.48% | 2 | Nov 1, 2022 | |
| A Agilent Technologies | Maintains: Outperform | $155 → $160 | $115.07 | +39.05% | 5 | Aug 17, 2022 | |
| EXAS Exact Sciences | Maintains: Outperform | $90 → $75 | $103.50 | -27.54% | 1 | Aug 3, 2022 |
Natera
Feb 27, 2026
Maintains: Outperform
Price Target: $239 → $257
Current: $198.13
Upside: +29.71%
Castle Biosciences
Feb 27, 2026
Maintains: Outperform
Price Target: $41 → $44
Current: $27.12
Upside: +62.24%
Illumina
Oct 31, 2025
Maintains: Neutral
Price Target: $105 → $109
Current: $124.62
Upside: -12.53%
Revvity
Oct 28, 2025
Maintains: Outperform
Price Target: $122 → $123
Current: $91.34
Upside: +34.66%
Waters
Jul 16, 2025
Maintains: Outperform
Price Target: $374 → $352
Current: $302.54
Upside: +16.35%
Twist Bioscience
May 6, 2025
Maintains: Outperform
Price Target: $54 → $44
Current: $46.94
Upside: -6.26%
Thermo Fisher Scientific
Nov 1, 2022
Maintains: Outperform
Price Target: $695 → $665
Current: $501.97
Upside: +32.48%
Agilent Technologies
Aug 17, 2022
Maintains: Outperform
Price Target: $155 → $160
Current: $115.07
Upside: +39.05%
Exact Sciences
Aug 3, 2022
Maintains: Outperform
Price Target: $90 → $75
Current: $103.50
Upside: -27.54%